By Erinn Connor
Medically Reviewed by Robert Jasmer, MD
For original article visit: http://www.everydayhealth.com/high-cholesterol/living-with/my-life-with-familial-hypercholesterolemia/
One patient with familial hypercholesterolemia took action after too many in her family died of heart attacks … Read More
October 17-18, 2016 | Dallas, TX
The FH Foundation’s 2016 FH Global Summit took place a stone’s throw away from the Brown/Goldstein Lab, where the LDL receptor was discovered.
In attendance were a group … Read More
Just 4 years ago, one of us (MJK) co-chaired the Familial Hypercholesterolemia (FH) Foundation’s first FH Global Summit: Awareness to Action held in Annapolis, Maryland. The Summit brought together people from academia, government, the private sector, clinicians, as well as patients with the ambitious … Read More
What Does News of Pfizer’s Discontinuation of PCSK9 Inhibitor Program Mean for FH Patients?
With the news that Pfizer, Inc has discontinued development of its PCSK9 inhibitor, bococizumab, the FH Foundation reached out to our Chief Scientific Advisor, Dan Rader, MD, Seymour Gray Professor of … Read More
